Injectable formulations are the fastest growing segment in the pharmaceutical industry. According to Precedence Research, the global injectable drug delivery market reached U.S. $561 billion in 2021 ...

Eisai’s 10 billion Japanese yen ($69 million) bet on injectable drug delivery is complete. The Japanese drug developer plowed the money into the construction of an injectable formulation research ...

Non-invasive delivery systems, like needle-free nasal sprays, improve patient adherence by addressing psychological barriers and offering logistical advantages such as extended shelf life and ...

For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole while a clear bag slowly empties into a vein. A new generation of ...

A once-a-week Parkinson’s injection could replace multiple daily pills, thanks to a new slow-release formulation developed by researchers. It promises easier treatment, fewer missed doses, and better ...

Covid-19 vaccinations have tempered the pandemic’s spread in the U.S., but infections are still happening and not everyone is eligible for the authorized shots. Those needing a Covid antibody ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate to severe ...

An analysis of data from the US Food and Drug Administration Adverse Event Reporting System (FAERS) database revealed differences in patterns of ocular events associated with oral and injectable ...